The latest market report published by Credence Research, Inc. “Intravenous Access Devices Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025,” the global intravenous access devices market was valued at US$ 5,086.74 Mn in 2016, and is expected to reach US$ 7,918.12 Mn by 2025 expanding at a CAGR of 5.1 % from 2017 to 2025.

Browse the full report Intravenous Access Devices Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/intravenous-access-devices-market

Market Insights:

The prominent market players are striving to eliminate complications such as phlebitis, extravasation, and hematoma by adding safety features to the catheters and cannulas used as an intravenous access devices. The device features such as encapsulated needle shield and clicking lock safety mechanism, smooth surface, delicate tapered catheter tips, and thumb grip being ergonomically designed enhances the safety and patient compliance of the intravenous access devices. Insyte autoguard shielded IV catheters (Becton and Dickinson) and Introcan safety 3 IV catheters (B. Braun Medical, Inc.) have been successful in addressing complication related to intravenous access devices.

The peripheral vascular access system leads the product segment as it is used for short term therapies for administration of antibiotics and antipyretic drugs which comes under first line treatment against infectious diseases. Central vascular access system finds significance for long term therapy used for the treatment of chronic diseases.

Rising prevalence of chronic diseases and intravenous drug administration for contagious diseases favor the domination of medication administration and diagnostic testing in the application segment. Increasing road accidents, malnutrition and blood disorders will highlight the impressive growth in transfusion of blood products and administration of fluid and nutrition in the application segment.

The consolidated market hold of North America is due to rising prevalence of both communicable and non-communicable diseases. Enhanced government spending in developing healthcare segment leads to increasing demand for intravenous access devices in North American market. In Asia Pacific the sultry weather conditions, poverty and pollution are responsible for increasing bacterial infections requiring immediate IV fluid and drug assistance. Competitive market is created by impressive growth of domestic players manufacturing intravenous access devices in Asia Pacific market.

The intravenous access devices market includes cardinal players such as Nipro Medical Corporation, Becton Dickinson and Company, Edward Life Sciences Corporation, Medtronic Plc, Baxter International, Inc., Siemens Medical Solutions, Inc., Teleflex Medical, GE Healthcare, Inc., Terumo Corporation and B. Braun Medical, Inc.

Key Market Movements:

  • Sedentary lifestyle, obesity and tobacco consumption in developed countries give rise to non-communicable diseases
  • Increasing poverty and pollution resulting in proliferation of communicable diseases in low and middle income countries
  • Supportive regulatory environment for intravenous access devices products

Browse the full report Intravenous Access Devices Market – Growth, Future Prospects, Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/intravenous-access-devices-market

 Latest Reports:

Oxygen Concentrators Market: http://www.credenceresearch.com/press/global-oxygen-concentrators-market

Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous). The intravenous route of administration can be used for injections (with a syringe at higher pressures) or infusions (typically using only the pressure supplied by gravity). Intravenous infusions are commonly referred to as drips. The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body, because the circulation carries them. Intravenous therapy may be used for fluid replacement (such as correcting dehydration), to correct electrolyte imbalances, to deliver medications, and for blood transfusions.

Source : Wikipideia

Risks of this IV device short-term outweigh benefits

A new study finds that 1 in 4 times health care providers insert a certain type of intravenous device, the patient doesn’t need it long enough to justify the risks of using it.These days, many hospital patients get medicine or nutrition delivered straight into their bloodstream through a tiny device called a PICC. In just a decade, these peripherally inserted central catheters have become the go-to device for intravenous care.However, in just the five days or less that patients had a PICC imserted in their vein, nearly 1 in 10  had a blocked line, an infection, a blood clot, or another complication linked to the device.

“…medical devices such as PICCs can be both helpful and harmful…”

Further, one in 3 short-term PICC patients also had serious kidney problems that could make them potential dialysis candidates, the study shows. They face special risks from the devices, which can harm blood vessels and jeopardize a patient’s ability to receive dialysis later, if their kidneys fail.

[Ref: futurity.org]

 

 

About:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com